Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Development of a safe and effective COVID-19 nanoparticle vaccine

Researchers from ReVacc scientific have attempted to demonstrate the effectiveness of a new vaccine, REVC-128, two weeks post-administration.

22 Oct 2021

Hydrogel-based vaccine delivery system evokes antibody response against SARS-CoV-2

Researchers from Stanford University have been attempting to create a hydrogel-based vaccine delivery system that could improve the immune response's strength and duration.

22 Oct 2021

SARS-CoV-2 cocktail with three antibodies potent in preclinical testing

Amidst growing concerns on the use and potential benefits of convalescent plasma therapy, a research group in the United States has identified three human antibodies (Abs) that, when combined, demonstrate both robust viral suppressive properties against all tested severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Variants of Concern (VoC) in vitro and profound antiviral efficacy in vivo.

22 Oct 2021

Vaccinating adolescents may reduce the impact of COVID-19, according to a UK modeling study

A recent study from the United Kingdom, published in the open-access journal Vaccines, implies that vaccinating adolescents and children may be pivotal in reducing infections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as ensuing coronavirus disease (COVID-19) morbidity and mortality across all age groups.

21 Oct 2021

Honeybees can be trained to identify SARS-CoV-2 infected samples, say scientists

In a recent study published on the bioRxiv* pre-print server, researchers from the Netherlands successfully trained honeybees (Apis mellifera) to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected minks (Neovison vison) using Pavlovian conditioning protocols.

21 Oct 2021

Comparative effectiveness of ChAdOx1 and BNT162b2 COVID-19 vaccines

In a recent study, researchers compared the efficacy of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines against infection SARS-CoV-2.

21 Oct 2021

Comparison of social distancing policies in Denmark and Sweden to combat COVID-19

The current study included the national response of Denmark and Sweden to the COVID-19 pandemic.

21 Oct 2021

Influence of age on innate and adaptive immunity in COVID-19 patients

A new study investigates how age influences SARS-CoV-2 replication, innate and adaptive immune responses.

21 Oct 2021

Development of a plant-based platform for the production of SARS-CoV-2 antigen

Scientists have recently focused on the development of plant-based recombinant protein platforms.

21 Oct 2021

Immune responses to SARS-CoV-2 infection and vaccination in patients with multiple sclerosis

A new study has focused on the immune response in pwMS undergoing anti-CD20 treatment.

21 Oct 2021

MRI study suggests link between SARS-CoV-2 and brain lesions in COVID-19 patients with pneumonia

New research suggests pneumonia in COVID-19 patients is linked to viral-induced changes in the brain. MRI scans revealed 57.9% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients had recent brain lesions.

20 Oct 2021

Broadly protective vaccines against coronaviruses needed to protect against future outbreaks

The coronavirus disease 2019 (COVID-19) pandemic, caused by the β-coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), alerted the world to the seriousness of the threat posed by novel viruses.

20 Oct 2021

How the public views COVID-19 vaccines via Twitter in the United States

A new study uses Twitter to examine public attitudes towards the vaccines developed to fight the COVID-19 in the United States.

20 Oct 2021

Children show lower seroconversion rates than adults with mild COVID-19

A new study finds that following mild COVID-19, children are more likely to remain seronegative than adults, irrespective of the viral load or symptom severity.

20 Oct 2021

New research on phagocytosis and SARS-CoV-2's spike protein

A new study showed that convalescent patient plasma and monoclonal anti-spike antibodies were able to induce phagocytosis at high antibody concentrations.

20 Oct 2021

Biomarker predicts severity of SARS-CoV-2 infection in patients

A new study investigates a biomarker to predict the severity of disease in patients infected with SARS-CoV-2.

20 Oct 2021

The neutralization potential of nanobodies against SARS-CoV-2

A recent review describes the role of nanobodies as a new class of recombinant antibodies that are used in the treatment of COVID-19.

20 Oct 2021

New oligomer shows promising anti-SARS-CoV-2 properties

Scientists from the University Of New Mexico have recently identified a new cationic oligomer that may help inactivate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

20 Oct 2021

Two doses of Pfizer-BioNTech vaccine effective in preventing COVID-19 hospitalization among adolescents

The Centres for Disease Control and Prevention conducted a study to determine the vaccination efficacy in the adolescent population, published recently.

20 Oct 2021

COVID-19 vaccination side effects in the USA

A new study described and compared self-reported side effects of three different COVID-19 vaccines administered between March 19 and July 15, 2021, in the United States.

20 Oct 2021

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Development of a safe and effective COVID-19 nanoparticle vaccine

Hydrogel-based vaccine delivery system evokes antibody response against SARS-CoV-2

SARS-CoV-2 cocktail with three antibodies potent in preclinical testing

Vaccinating adolescents may reduce the impact of COVID-19, according to a UK modeling study

Honeybees can be trained to identify SARS-CoV-2 infected samples, say scientists

Comparative effectiveness of ChAdOx1 and BNT162b2 COVID-19 vaccines

Comparison of social distancing policies in Denmark and Sweden to combat COVID-19

Influence of age on innate and adaptive immunity in COVID-19 patients

Development of a plant-based platform for the production of SARS-CoV-2 antigen

Immune responses to SARS-CoV-2 infection and vaccination in patients with multiple sclerosis

MRI study suggests link between SARS-CoV-2 and brain lesions in COVID-19 patients with pneumonia

Broadly protective vaccines against coronaviruses needed to protect against future outbreaks

How the public views COVID-19 vaccines via Twitter in the United States

Children show lower seroconversion rates than adults with mild COVID-19

New research on phagocytosis and SARS-CoV-2's spike protein

Biomarker predicts severity of SARS-CoV-2 infection in patients

The neutralization potential of nanobodies against SARS-CoV-2

New oligomer shows promising anti-SARS-CoV-2 properties

Two doses of Pfizer-BioNTech vaccine effective in preventing COVID-19 hospitalization among adolescents

COVID-19 vaccination side effects in the USA

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in